developed a novel tumor‐targeting pH‐responsive nanomaterial for delivering the antibacterial fatty acid lauric acid (LA) and the chemotherapeutic drug oxaliplatin (OXA) to effectively eliminate extracellular and intracellular Fn in the acidic TME. This evidence concerns the gene FN1 and neoplasm.